{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T11:33:42Z","timestamp":1772710422428,"version":"3.50.1"},"reference-count":14,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.schres.2022.12.031","type":"journal-article","created":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T13:04:39Z","timestamp":1672923879000},"page":"10-12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Thyroid hormone optimize management in electroconvulsive therapy treatment of schizophrenia"],"prefix":"10.1016","volume":"252","author":[{"given":"Kun","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiang","family":"Long","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minne","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianning","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bochao","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaojian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanjun","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2022.12.031_bb0005","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/00124509-200412000-00011","article-title":"Effects of electroconvulsive therapy on the thyrotropin-releasing hormone test in patients with depression","volume":"20","author":"Esel","year":"2004","journal-title":"J. ECT"},{"key":"10.1016\/j.schres.2022.12.031_bb0010","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/S0278-5846(02)00256-7","article-title":"Effects of electroconvulsive therapy on hypothalamic-pituitary-thyroid axis activity in depressed patients","volume":"26","author":"Esel","year":"2002","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.schres.2022.12.031_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2012.03.025","article-title":"Functional impairment in people with schizophrenia: focus on employability and eligibility for disability compensation","volume":"140","author":"Harvey","year":"2012","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2022.12.031_bb0020","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/acps.13134","article-title":"When to consider electroconvulsive therapy (ECT)","volume":"141","author":"Kellner","year":"2020","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.schres.2022.12.031_bb0025","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/503918","article-title":"Preventive effect of liothyronine on electroconvulsive therapy-induced memory deficit in patients with major depressive disorder: a double-blind controlled clinical trial","volume":"2015","author":"Mohagheghi","year":"2015","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.schres.2022.12.031_bb0030","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.19m13164","article-title":"Outcomes of youth treated with electroconvulsive therapy: a retrospective cohort study","volume":"82","author":"Pierson","year":"2021","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2022.12.031_bb0035","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jad.2021.11.055","article-title":"Exploring the potential of thyroid hormones to predict clinical improvements in depressive patients: a machine learning analysis of the real-world based study","volume":"299","author":"Qiao","year":"2022","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.schres.2022.12.031_bb0040","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1136\/bmj.326.7403.1363","article-title":"Patients' perspectives on electroconvulsive therapy: systematic review","volume":"326","author":"Rose","year":"2003","journal-title":"BMJ (Clinical research ed.)"},{"key":"10.1016\/j.schres.2022.12.031_bb0045","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1192\/bjp.2021.61","article-title":"Rates of treatment-resistant schizophrenia from first-episode cohorts: systematic review and meta-analysis","volume":"220","author":"Siskind","year":"2022","journal-title":"Br. J. Psychiatry J. Ment. Sci."},{"key":"10.1016\/j.schres.2022.12.031_bb0050","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/0006-3223(91)90032-H","article-title":"Antidepressant and memory effects of combined thyroid hormone treatment and electroconvulsive therapy: preliminary findings","volume":"30","author":"Stern","year":"1991","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.schres.2022.12.031_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40261-019-00854-w","article-title":"Targeting hormones for improving cognition in major mood disorders and schizophrenia: thyroid hormones and prolactin","volume":"40","author":"Tost","year":"2020","journal-title":"Clin. Drug Investig."},{"key":"10.1016\/j.schres.2022.12.031_bb0060","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1017\/S1461145700001838","article-title":"Minimizing the cognitive effects of lithium therapy and electroconvulsive therapy using thyroid hormone","volume":"3","author":"Tremont","year":"2000","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.schres.2022.12.031_bb0065","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/acps.13397","article-title":"Pharmacological interventions to diminish cognitive side effects of electroconvulsive therapy: a systematic review and meta-analysis","volume":"145","author":"Verdijk","year":"2022","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.schres.2022.12.031_bb0070","doi-asserted-by":"crossref","DOI":"10.1017\/erm.2015.8","article-title":"Thyroid hormone in the frontier of cell protection, survival and functional recovery","volume":"17","author":"Videla","year":"2015","journal-title":"Expert Rev. Mol. Med."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996422004789?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996422004789?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:49:43Z","timestamp":1760298583000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996422004789"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":14,"alternative-id":["S0920996422004789"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2022.12.031","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thyroid hormone optimize management in electroconvulsive therapy treatment of schizophrenia","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2022.12.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}